Mechanism of action potential prolongation by RP 58866 and its active enantiomer, terikalant. Block of the rapidly activating delayed rectifier K+ current, IKr

Circulation
N K JurkiewiczJ J Salata

Abstract

The class III antiarrhythmic agent RP 58866 and its active enantiomer, terikalant, are reported to selectively block the inward rectifier K+ current, IK1. These drugs have demonstrated efficacy in animal models of cardiac arrhythmias, suggesting that block of IK1 may be a useful antiarrhythmic mechanism. The symmetrical action potential (AP)-prolonging and bradycardic effects of these drugs, however, are inconsistent with a sole effect on IK1. We studied the effects of RP 58866 and terikalant on AP and outward K+ currents in guinea pig ventricular myocytes. RP 58866 and terikalant potently blocked the rapidly activating delayed rectifier K+ current, IKr, with IC50S of 22 and 31 nmol/L, respectively. Block of IK1 was approximately 250-fold less potent; IC50S were 8 and 6 mumol/L, respectively. No significant block of the slowly activating delayed rectifier, IK1, was observed at < or = 10 mumol/L. The phenotypical IKr currents in mouse AT-1 cells and Xenopus oocytes expressing HERG were also blocked 50% by 200 to 250 nmol/L RP 58866 or terikalant, providing further conclusive evidence for potent block of IKr. RP 58866 < or = 1 mumol/L and dofetilide increased AP duration symmetrically, consistent with selective block of IKr. Only...Continue Reading

References

Mar 1, 1992·The Journal of Physiology·Y ShimoniW R Giles
Feb 1, 1992·Pflügers Archiv : European journal of physiology·M C Sanguinetti, N K Jurkiewicz
Jan 1, 1992·The American Journal of Physiology·C H FollmerT J Colatsky
Jul 1, 1991·The American Journal of Physiology·Z Fan, M Hiraoka
Nov 1, 1984·Pflügers Archiv : European journal of physiology·T NakayamaH Irisawa
Dec 1, 1994·Journal of Cardiovascular Electrophysiology·Y LiuM Delmar
Mar 1, 1994·Cardiovascular Research·S A Rees, M J Curtis
Mar 1, 1994·Cardiovascular Research·T Opthof
May 1, 1996·The Journal of General Physiology·P S SpectorM C Sanguinetti
Jul 1, 1993·Trends in Cardiovascular Medicine·R S Kass, L C Freeman

❮ Previous
Next ❯

Citations

Jun 6, 2007·Journal of Computer-aided Molecular Design·David J Diller, Doug W Hobbs
Mar 15, 2005·European Journal of Pharmacology·Péter BiliczkiAndrás Varró
Aug 4, 2004·Progress in Biophysics and Molecular Biology·William BainsCat White
Jun 30, 2001·European Journal of Pharmacology·B M DumotierM M Adamantidis
Aug 7, 2002·European Journal of Pharmacology·András Farkas, Susan J Coker
May 20, 1999·European Journal of Pharmacology·S E JonesT F McDonald
Oct 24, 1998·Progress in Biophysics and Molecular Biology·E Carmeliet, K Mubagwa
Mar 4, 1998·British Journal of Pharmacology·A E BuschF Lang
Sep 14, 1999·British Journal of Pharmacology·H WangZ Wang
Sep 5, 2002·British Journal of Pharmacology·Edgar ZitronJohann Kiehn
Jan 16, 2002·Journal of Cardiovascular Pharmacology·Xiangqian QiPaul Dorian
Jan 5, 2001·Pacing and Clinical Electrophysiology : PACE·B BrandtsH J Trappe
Mar 25, 1999·Journal of Cardiovascular Electrophysiology·S Nattel
Jan 24, 2003·Annual Review of Pharmacology and Toxicology·Colleen E ClancyRobert S Kass
Jan 5, 2001·Clinical Chemistry and Laboratory Medicine : CCLM·O ChenillotG Siest
Jul 4, 2012·Biochemical and Biophysical Research Communications·Martin KulzerEdgar Zitron
Aug 25, 2004·Bioorganic & Medicinal Chemistry Letters·Lü-Pei DuLin Xia
Jan 22, 2009·PloS One·Karen Mruk, William R Kobertz
May 15, 2009·Journal of Pharmacological and Toxicological Methods·Rob TowartDavid J Gallacher
Jul 24, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Jingdong LiAnatoli N Lopatin
Dec 25, 2004·Physiological Reviews·Colleen E Clancy, Robert S Kass
Jul 11, 1998·Molecular Pharmacology·J J SalataM C Sanguinetti
Sep 24, 1998·The American Journal of Physiology·S J RialsP R Kowey
Aug 15, 2002·Cardiovascular Drug Reviews·Christoph A KarleJohann Kiehn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.